Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tabari Cohort Profile and Preliminary Results in Urban Areas and Mountainous Regions of Mazandaran, Iran.
Kheradmand M, Moosazadeh M, Saeedi M, Poustchi H, Eghtesad S, Esmaeili R, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Nikaeein R, Rafiei A, Janbabaee G, Kashi Z, Sohrab M, Shirzad AhooDashti M, Afshari M, Golpour B, Aarabi M, Maleki I, Tirgar Fakheri H, Ghaemian A, Zarghami M, Ghaemi A. Kheradmand M, et al. Among authors: tirgar fakheri h. Arch Iran Med. 2019 Jun 1;22(6):279-285. Arch Iran Med. 2019. PMID: 31356093
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
Abbaspour Kasgari H, Moradi S, Shabani AM, Babamahmoodi F, Davoudi Badabi AR, Davoudi L, Alikhani A, Hedayatizadeh Omran A, Saeedi M, Merat S, Wentzel H, Garratt A, Levi J, Simmons B, Hill A, Tirgar Fakheri H. Abbaspour Kasgari H, et al. Among authors: tirgar fakheri h. J Antimicrob Chemother. 2020 Nov 1;75(11):3373-3378. doi: 10.1093/jac/dkaa332. J Antimicrob Chemother. 2020. PMID: 32812025 Free PMC article. Clinical Trial.
Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacterpylori eradication.
Kazemi Veysari A, Rahimi A, Maleki I, Tirgar Fakheri H, Taghvaei T, Hosseini V, Valizadeh Toosi SM, Masoumi D, Bari Z. Kazemi Veysari A, et al. Among authors: tirgar fakheri h. Caspian J Intern Med. 2023 Fall;14(4):676-680. doi: 10.22088/cjim.14.4.676. Caspian J Intern Med. 2023. PMID: 38024162 Free PMC article.
Acute bleeding in duodenal gastrointestinal stromal tumor.
Mokhtare M, Taghvaei T, Tirgar Fakheri H. Mokhtare M, et al. Among authors: tirgar fakheri h. Middle East J Dig Dis. 2013 Jan;5(1):47-51. Middle East J Dig Dis. 2013. PMID: 24829670 Free PMC article.
Erratum Erratum to: Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
Simmons B, Wentzel H, Mobarak S, Eslami G, Sadeghi A, Ali Asgari A, Abbaspour Kasgari H, Tirgar Fakheri H, Merat S, Hill A. Simmons B, et al. Among authors: tirgar fakheri h. J Antimicrob Chemother. 2021 May 12;76(6):1653. doi: 10.1093/jac/dkab030. J Antimicrob Chemother. 2021. PMID: 33704468 Free PMC article. No abstract available.
Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of Helicobacter pylori: a randomized, double-blind clinical trial.
Mansour-Ghanaei F, Samadi A, Joukar F, Tirgar Fakheri H, Hassanipour S, Ashoobi MT, Soltanipour S, Alizadeh A, Rezamand G, Fathalipour M. Mansour-Ghanaei F, et al. Among authors: tirgar fakheri h. EXCLI J. 2019 Aug 19;18:644-652. doi: 10.17179/excli2019-1613. eCollection 2019. EXCLI J. 2019. PMID: 31611747 Free PMC article.
11 results